Total Payments
$7,294
2024 Payments
$2,634
Companies
19
Transactions
343
Medicare Patients
727
Medicare Billing
$82,938
Payment Breakdown by Category
Food & Beverage$6,667 (91.4%)
Consulting$400.00 (5.5%)
Education$227.48 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,667 | 339 | 91.4% |
| Consulting Fee | $400.00 | 1 | 5.5% |
| Education | $227.48 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,529 | 120 | $0 (2024) |
| PFIZER INC. | $801.58 | 39 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $741.10 | 36 | $0 (2024) |
| Lilly USA, LLC | $491.21 | 26 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $454.68 | 23 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $416.82 | 11 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $412.12 | 20 | $0 (2022) |
| Amgen Inc. | $310.44 | 15 | $0 (2023) |
| Lundbeck LLC | $305.55 | 10 | $0 (2024) |
| UPSHER-SMITH LABORATORIES LLC | $299.42 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,634 | 113 | ABBVIE INC. ($1,376) |
| 2023 | $2,151 | 106 | ABBVIE INC. ($768.02) |
| 2022 | $1,496 | 78 | Biohaven Pharmaceutical Holding Company Ltd. ($412.12) |
| 2021 | $1,013 | 46 | Biohaven Pharmaceuticals, Inc. ($416.82) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: PAIN | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $78.49 | General |
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: PAIN | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 156 | 295 | $125,235 | $19,864 |
| 2022 | 5 | 188 | 342 | $131,445 | $21,718 |
| 2021 | 5 | 199 | 360 | $132,520 | $24,755 |
| 2020 | 5 | 184 | 286 | $105,795 | $16,601 |
Total Patients
727
Total Services
1,283
Medicare Billing
$82,938
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 70 | 141 | $61,335 | $11,531 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 72 | $19,800 | $4,585 | 23.2% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Facility | 2023 | 15 | 30 | $16,800 | $1,724 | 10.3% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Facility | 2023 | 16 | 40 | $24,000 | $1,431 | 6.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $3,300 | $593.64 | 18.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 71 | 142 | $61,770 | $11,487 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 62 | $14,170 | $4,111 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 44 | $6,215 | $2,025 | 32.6% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Facility | 2022 | 19 | 49 | $29,400 | $1,862 | 6.3% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Facility | 2022 | 14 | 31 | $17,360 | $1,728 | 10.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $2,530 | $505.67 | 20.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 68 | 142 | $61,770 | $13,173 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 51 | 86 | $15,910 | $5,875 | 36.9% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Facility | 2021 | 19 | 39 | $21,840 | $2,295 | 10.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 42 | 48 | $6,000 | $1,979 | 33.0% |
| 64400 | Injection of anesthetic agent and/or steroid into trigeminal nerve of face | Facility | 2021 | 19 | 45 | $27,000 | $1,434 | 5.3% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 66 | 106 | $46,110 | $8,454 | 18.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 34 | 52 | $9,620 | $2,696 | 28.0% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Facility | 2020 | 23 | 39 | $21,840 | $2,353 | 10.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 41 | 53 | $6,625 | $2,014 | 30.4% |
| 64400 | Injection of anesthetic agent and/or steroid into trigeminal nerve of face | Facility | 2020 | 20 | 36 | $21,600 | $1,084 | 5.0% |
About Kristopher Medina
Kristopher Medina is a Family healthcare provider based in Paoli, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1124416185.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristopher Medina has received a total of $7,294 in payments from pharmaceutical and medical device companies, with $2,634 received in 2024. These payments were reported across 343 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($6,667).
As a Medicare-enrolled provider, Medina has provided services to 727 Medicare beneficiaries, totaling 1,283 services with total Medicare billing of $82,938. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Paoli, PA
- Active Since 12/29/2014
- Last Updated 10/13/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1124416185
Products in Payments
- NURTEC ODT (Drug) $1,529
- UBRELVY (Drug) $1,037
- BOTOX (Biological) $931.14
- EMGALITY (Drug) $491.21
- Trudhesa (Drug) $454.68
- QULIPTA (Drug) $411.40
- AJOVY (Biological) $331.36
- Aimovig (Biological) $310.44
- VYEPTI (Biological) $305.55
- ZEMBRACE SYMTOUCH (Drug) $165.72
- TOSYMRA (Drug) $162.39
- Austedo XR (Drug) $129.48
- ZTLido (Drug) $91.98
- COMIRNATY (Biological) $73.99
- AUSTEDO (Drug) $52.78
- Dysport (Drug) $48.95
- ELYXYB - celecoxib (Drug) $44.77
- PAXLOVID (Drug) $27.22
- QUVIVIQ (Drug) $17.99
- ZOMIG (Drug) $14.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Paoli
Shannon Dooley, N. P, N. P
Family — Payments: $3,359
Family $3,359
Kathryn Poole
Family — Payments: $2,878
Family $2,878
Jaclynn Thacker, Aprn, Np-C, APRN, NP-C
Family — Payments: $1,171
Family $1,171
Mrs. Allison Mcaleer
Family — Payments: $1,081
Family $1,081
Mrs. Judith Kelley, Crnp, CRNP
Family — Payments: $1,019
Family $1,019
Ruth Brobst, Msn Crnp, MSN CRNP
Family — Payments: $950.21
Family $950.21